Recent studies have reported the presence of biallelic PMS2 mutations in up to 60% of patients with CMMRD [31] in contrast to LS patients, the large majority of whom are carriers of MLH1 and MSH2 mutations. This evidence concerns the gene PMS2 and Leigh syndrome.